文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

通过微阵列分析和基于光学相干断层扫描的亚分析在湿性年龄相关性黄斑变性患者的房水细胞因子水平。

Aqueous humor cytokine levels through microarray analysis and a sub-analysis based on optical coherence tomography in wet age-related macular degeneration patients.

机构信息

Department of Ophthalmology, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul, Republic of Korea.

Barunbit EYE Clinic, Seoul, Republic of Korea.

出版信息

BMC Ophthalmol. 2021 Nov 18;21(1):399. doi: 10.1186/s12886-021-02152-6.


DOI:10.1186/s12886-021-02152-6
PMID:34794403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8603589/
Abstract

BACKGROUND: To identify disease-specific cytokine and growth factor profile differences in the aqueous humor between wet age-related macular degeneration (AMD) patients and age-matched controls and to correlate their levels with the optical coherence tomography (OCT) findings. METHODS: Aqueous humors were obtained from 13 wet AMD eyes and 10 control eyes. Twenty cytokines and growth factors were measured using a RayBio antibody microarray technology in wet AMD and control eyes. RESULTS: The samples obtained from wet AMD patients exhibited a significantly increased expression of MCP-1, MIP-1α, MIP-1β, and vascular endothelial growth factor (VEGF). Subretinal fluid (SRF) patients showed significantly lower levels of proinflammatory cytokines, such as IL-1α and GM-CSF, than those without SRF. Pigment epithelial detachments (PED) patients showed lower levels of inflammatory cytokines, such as GM-CSF, IFN-γ, and TNF-α, than those without PED. Subretinal tissue (SRT) patients showed a higher level of IFN-γ than those without SRT. Compared with the controls, type 1 macular neovascularization (MNV) patients showed increased levels of MCP-1, MIP-1α, and MIP-1β, but not VEGF (p = 0.083). However, type 2 MNV patients showed increased levels of MCP-1 and VEGF (p = 0.040 and p = 0.040). CONCLUSION: Inflammatory cytokines varied according to the type of AMD- and OCT-based parameters. Our observation of low levels of VEGF in patients with type 1 MNV implies that the inhibition of VEGF alone appears to be insufficient treatment for these patients and that cytokines such as MCP-1, MIP-1α, and MIP-1β should be modulated. And the presence of SRF in MNV may be associated with a positive prognosis because we found relatively low levels of proinflammatory cytokines.

摘要

背景:为了鉴定湿性年龄相关性黄斑变性(AMD)患者和年龄匹配对照者房水中的特定疾病细胞因子和生长因子谱差异,并将其与光学相干断层扫描(OCT)结果相关联。

方法:从 13 例湿性 AMD 眼和 10 例对照眼获得房水。使用 RayBio 抗体微阵列技术在湿性 AMD 和对照眼中测量了 20 种细胞因子和生长因子。

结果:从湿性 AMD 患者获得的样本显示 MCP-1、MIP-1α、MIP-1β 和血管内皮生长因子(VEGF)的表达显著增加。与无 SRF 的患者相比,有 SRF 的患者的前炎症细胞因子(如 IL-1α 和 GM-CSF)水平显著降低。有 PED 的患者的炎症细胞因子(如 GM-CSF、IFN-γ 和 TNF-α)水平低于无 PED 的患者。与无 SRT 的患者相比,有 SRT 的患者的 IFN-γ 水平较高。与对照组相比,1 型黄斑新生血管(MNV)患者的 MCP-1、MIP-1α 和 MIP-1β 水平升高,但 VEGF 水平未升高(p=0.083)。然而,2 型 MNV 患者的 MCP-1 和 VEGF 水平升高(p=0.040 和 p=0.040)。

结论:根据 AMD 和基于 OCT 的参数的类型,炎症细胞因子会发生变化。我们观察到 1 型 MNV 患者的 VEGF 水平较低,这表明单独抑制 VEGF 似乎不足以治疗这些患者,应该调节 MCP-1、MIP-1α 和 MIP-1β 等细胞因子。并且 MNV 中存在 SRF 可能与良好的预后相关,因为我们发现前炎症细胞因子的水平相对较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c685/8603589/4b986f82d718/12886_2021_2152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c685/8603589/d9f513af69f7/12886_2021_2152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c685/8603589/4b986f82d718/12886_2021_2152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c685/8603589/d9f513af69f7/12886_2021_2152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c685/8603589/4b986f82d718/12886_2021_2152_Fig2_HTML.jpg

相似文献

[1]
Aqueous humor cytokine levels through microarray analysis and a sub-analysis based on optical coherence tomography in wet age-related macular degeneration patients.

BMC Ophthalmol. 2021-11-18

[2]
Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection.

Retina. 2014-9

[3]
Aqueous humor cytokine profiling in patients with wet AMD.

Mol Vis. 2016-4-22

[4]
Clinical characteristics and visual outcomes of non-resolving subretinal fluid in neovascular AMD despite continuous monthly anti-VEGF injections: a long-term follow-up.

Graefes Arch Clin Exp Ophthalmol. 2021-5

[5]
Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.

Ophthalmic Res. 2015

[6]
Dynamics of Inflammatory Factors in Aqueous Humor during Ranibizumab or Aflibercept Treatment for Age-Related Macular Degeneration.

Ophthalmic Res. 2017

[7]
Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.

BMC Ophthalmol. 2021-8-10

[8]
Non-neovascular age-related macular degeneration with subretinal fluid.

Br J Ophthalmol. 2021-10

[9]
Theoretical Insights into the Retinal Dynamics of Vascular Endothelial Growth Factor in Patients Treated with Ranibizumab, Based on an Ocular Pharmacokinetic/Pharmacodynamic Model.

Mol Pharm. 2018-5-29

[10]
Aqueous humor cytokine levels in patients with subretinal fibrosis in neovascular age-related macular degeneration.

BMC Ophthalmol. 2024-8-12

引用本文的文献

[1]
Pharmacoproteomics in the development of personalised medicine in Age-related Macular Degeneration (PHARPRO-AMD) study protocol.

BMJ Open Ophthalmol. 2025-8-24

[2]
Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study.

J Transl Med. 2025-3-12

[3]
Aqueous Humor Cytokine Analysis in Age-Related Macular Degeneration After Switching From Aflibercept to Faricimab.

Invest Ophthalmol Vis Sci. 2024-9-3

[4]
Topical Ophthalmic Liposomes Dual-Modified with Penetratin and Hyaluronic Acid for the Noninvasive Treatment of Neovascular Age-Related Macular Degeneration.

Int J Nanomedicine. 2024

[5]
CCR1 mediates Müller cell activation and photoreceptor cell death in macular and retinal degeneration.

Elife. 2023-10-30

[6]
Systemic Blood Proteome Patterns Reflect Disease Phenotypes in Neovascular Age-Related Macular Degeneration.

Int J Mol Sci. 2023-6-19

[7]
Cytokine profiles in the aqueous humor following brolucizumab administration for exudative age-related macular degeneration.

Graefes Arch Clin Exp Ophthalmol. 2023-9

[8]
Retinal fluid is associated with cytokines of aqueous humor in age-related macular degeneration using automatic 3-dimensional quantification.

Front Cell Dev Biol. 2023-3-8

[9]
Association of IL-4 with pachychoroid neovasculopathy.

Sci Rep. 2023-1-20

[10]
Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review.

Int J Mol Sci. 2022-11-25

本文引用的文献

[1]
Cytokine Profiles and the Effect of Intravitreal Aflibercept Treatment on Experimental Choroidal Neovascularization.

Ophthalmic Res. 2022

[2]
Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.

Ophthalmol Retina. 2021-2

[3]
Aqueous Fluid as a Viable Substitute for Vitreous Fluid in Postmortem Chemistry Analysis.

J Forensic Sci. 2020-3

[4]
Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! Project.

Am J Ophthalmol. 2019-3-9

[5]
Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion.

BMC Ophthalmol. 2019-1-8

[6]
A Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL/6 and BALB/c Mice.

Int J Mol Sci. 2017-2-26

[7]
Inflammation and its role in age-related macular degeneration.

Cell Mol Life Sci. 2016-5

[8]
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration.

Prog Retin Eye Res. 2015-8-22

[9]
Defining response to anti-VEGF therapies in neovascular AMD.

Eye (Lond). 2015-6

[10]
Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab.

Ophthalmology. 2015-4-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索